Michael E. Tarvin - 29 Jul 2025 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Jul 2025, 16:58:58 UTC
Prior SEC filing
01 May 2025
Next SEC filing
04 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael E. Tarvin

Key filing fact

Michael E. Tarvin filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 31 Jul 2025.

Key facts

  • This page summarizes Michael E. Tarvin's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Jul 2025, 16:58.

Change

  • Previous filing in this sequence was filed on 01 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001168884 Primary reporting owner

TARVIN MICHAEL E

Relationship
EXECUTIVE VICE PRESIDENT
Address
C/O SELECT MEDICAL HOLDINGS CORPORATION, 4714 GETTYSBURG ROAD, MECHANICSBURG
Signature
/s/ Michael E. Tarvin
Signature date
31 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SEM transaction

Common Stock

Award

Transaction value
$0
Shares
+100,000
Change %
+23%
Price
$0.000000
Shares after
527,760
Date
29 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of restricted stock which will vest in equal annual installments over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .